CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM NEW
Total 13F shares
6,995,171
Share change
-244,863
Total reported value
$35,809,682
Price per share
$5.12
Number of holders
41
Value change
-$313,832
Number of buys
28
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q1 2020

As of 31 Mar 2020, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,995,171 shares. The largest 10 holders included Nantahala Capital Management, LLC, ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, SEGALL BRYANT & HAMILL, LLC, AWM Investment Company, Inc., INGALLS & SNYDER LLC, FRIESS ASSOCIATES LLC, ARS Investment Partners, LLC, BlackRock Inc., and Penbrook Management LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.